News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,733 Results
Type
Article (42289)
Company Profile (436)
Press Release (671008)
Multimedia
Podcasts (77)
Webinars (13)
Section
Business (208728)
Career Advice (2021)
Deals (36005)
Drug Delivery (104)
Drug Development (83572)
Employer Resources (173)
FDA (16426)
Job Trends (15094)
News (352774)
Policy (33077)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2643)
Accelerated approval (6)
Adcomms (24)
Allergies (84)
Alliances (50949)
ALS (93)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (135)
Approvals (16413)
Artificial intelligence (261)
Autoimmune disease (25)
Automation (16)
Bankruptcy (372)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (330)
Bladder cancer (68)
Brain cancer (26)
Breast cancer (279)
Cancer (2201)
Cardiovascular disease (182)
Career advice (1688)
Career pathing (30)
CAR-T (152)
Cell therapy (429)
Cervical cancer (19)
Clinical research (67699)
Collaboration (859)
Compensation (526)
Complete response letters (24)
COVID-19 (2644)
CRISPR (42)
C-suite (242)
Cystic fibrosis (105)
Data (2122)
Decentralized trials (2)
Denatured (28)
Depression (49)
Diabetes (267)
Diagnostics (6414)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (126)
Drug pricing (106)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (87653)
Editorial (39)
Employer branding (21)
Employer resources (147)
Events (115616)
Executive appointments (724)
FDA (17653)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (775)
Gene editing (109)
Generative AI (20)
Gene therapy (313)
GLP-1 (742)
Government (4498)
Grass and pollen (4)
Guidances (51)
Healthcare (19143)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (126)
Indications (29)
Infectious disease (2787)
Inflammatory bowel disease (140)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (94)
Interviews (311)
IPO (16781)
IRA (43)
Job creations (3700)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (491)
Leadership (17)
Legal (7985)
Liver cancer (73)
Lung cancer (317)
Lymphoma (148)
Machine learning (5)
Management (58)
Manufacturing (303)
MASH (67)
Medical device (13506)
Medtech (13511)
Mergers & acquisitions (19746)
Metabolic disorders (703)
Multiple sclerosis (79)
NASH (19)
Neurodegenerative disease (97)
Neuropsychiatric disorders (33)
Neuroscience (1978)
NextGen: Class of 2025 (6755)
Non-profit (4547)
Northern California (2613)
Now hiring (39)
Obesity (381)
Opinion (223)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (82)
Parkinson's disease (153)
Partnered (21)
Patents (230)
Patient recruitment (105)
Peanut (47)
People (58633)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21265)
Phase II (29874)
Phase III (22094)
Pipeline (1157)
Policy (141)
Postmarket research (2601)
Preclinical (9079)
Press Release (67)
Prostate cancer (103)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (398)
Real estate (6014)
Recruiting (66)
Regulatory (22692)
Reports (46)
Research institute (2415)
Resumes & cover letters (351)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (137)
Series B (89)
Service/supplier (11)
Sickle cell disease (57)
Southern California (2257)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3761)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (32)
The Weekly (47)
United States (22983)
Vaccines (692)
Venture capitalists (43)
Weight loss (252)
Women's health (37)
Worklife (16)
Date
Today (207)
Last 7 days (573)
Last 30 days (2534)
Last 365 days (33820)
2025 (10016)
2024 (36301)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (736)
Alabama (57)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (39213)
Australia (6527)
California (6036)
Canada (1977)
China (512)
Colorado (265)
Connecticut (278)
Delaware (141)
Europe (85664)
Florida (879)
Georgia (203)
Idaho (57)
Illinois (537)
India (25)
Indiana (309)
Iowa (11)
Japan (159)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (889)
Massachusetts (4590)
Michigan (218)
Minnesota (389)
Mississippi (2)
Missouri (81)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (66)
New Jersey (1711)
New Mexico (30)
New York (1708)
North Carolina (1016)
North Dakota (7)
Northern California (2613)
Ohio (202)
Oklahoma (14)
Oregon (38)
Pennsylvania (1344)
Puerto Rico (11)
Rhode Island (33)
South America (1110)
South Carolina (21)
South Dakota (1)
Southern California (2257)
Tennessee (101)
Texas (899)
Utah (177)
Virginia (145)
Washington D.C. (63)
Washington State (563)
West Virginia (3)
Wisconsin (53)
713,733 Results for "panbela therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
Panbela Therapeutics, Inc., a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, announces an oral presentation at the Digestive Disease Week conference, which was held May 18-21, 2024.
June 10, 2024
·
8 min read
BioMidwest
Panbela Announces Transfer to OTCQB Market
Panbela Therapeutics, Inc., a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced that its common stock has been approved for quotation on the OTCQB market.
April 16, 2024
·
7 min read
Drug Development
Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
Panbela Therapeutics, Inc. today announced that the independent Data Safety Monitoring Board (DSMB) has completed its third pre-specified safety review of the ongoing Phase 3 ASPIRE clinical trial evaluating ivospemin in combination with gemcitabine and nab-Paclitaxel for the first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC).
June 24, 2024
·
9 min read
Business
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on May 15, 2024, at 4:30 PM Eastern Time to discuss results for its first quarter ended March 31, 2024.
May 1, 2024
·
6 min read
Business
Panbela Provides Business Update and Reports Q1 2024 Financial Results
Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended March 31, 2024
May 15, 2024
·
13 min read
BioMidwest
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025Trial’s lower-than-expected event rate suggests improved survival outcomes
Panbela Therapeutics, Inc. today announced that the interim data analysis for its ongoing ASPIRE trial is now expected to be available as soon as Q1 2025.
April 22, 2024
·
8 min read
Policy
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, announced an Issue Notification for the US continuation patent US 11,925,613 B2 and Canadian patent CA 3003149.
May 6, 2024
·
7 min read
BioMidwest
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”) today announced that it will host a conference call on March 26, 2024, at 4:30 PM Eastern Time to discuss results for its fourth quarter and year ended December 31, 2023.
March 12, 2024
·
6 min read
Business
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter and full year ended December 31, 2023.
March 26, 2024
·
14 min read
Press Releases
Panbela Provides Business Update and Reports Q3 2024 Financial Results
November 15, 2024
·
13 min read
1 of 71,374
Next
